Earnings Report: Here’s what to expect from Nevro (NYSE:NVRO)

0
52

Earnings results for Nevro (NYSE:NVRO)

Nevro Corp. is expected* to report earnings on 05/05/2021 after market close. The report will be for the fiscal Quarter ending Mar 2021. According to Zacks Investment Research, based on 9 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.86. The reported EPS for the same quarter last year was $-0.78.

Nevro last released its quarterly earnings results on February 23rd, 2021. The medical equipment provider reported ($0.21) EPS for the quarter, topping the consensus estimate of ($0.33) by $0.12. The business earned $109.73 million during the quarter, compared to the consensus estimate of $109.82 million. Nevro has generated ($3.37) earnings per share over the last year. Nevro has confirmed that its next quarterly earnings report will be published on Wednesday, May 5th, 2021. Nevro will be holding an earnings conference call on Wednesday, May 5th. Interested parties can register for or listen to the call using this link.

Analyst Opinion on Nevro (NYSE:NVRO)

14 Wall Street analysts have issued ratings and price targets for Nevro in the last 12 months. Their average twelve-month price target is $181.38, predicting that the stock has a possible upside of 6.81%. The high price target for NVRO is $217.00 and the low price target for NVRO is $100.00. There are currently 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of “Buy.”

Nevro has received a consensus rating of Buy. The company’s average rating score is 2.79, and is based on 11 buy ratings, 3 hold ratings, and no sell ratings. According to analysts’ consensus price target of $181.38, Nevro has a forecasted upside of 6.8% from its current price of $169.82. Nevro has only been the subject of 3 research reports in the past 90 days.

Dividend Strength: Nevro (NYSE:NVRO)

Nevro does not currently pay a dividend. Nevro does not have a long track record of dividend growth.

Insiders buying/selling: Nevro (NYSE:NVRO)

In the past three months, Nevro insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $247,972.00 in company stock. Only 7.60% of the stock of Nevro is held by insiders.

Earnings and Valuation of Nevro (NYSE:NVRO

Earnings for Nevro are expected to grow in the coming year, from ($2.64) to ($1.66) per share. The P/E ratio of Nevro is -62.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Nevro is -62.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Nevro has a P/B Ratio of 24.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here